APO Research
Talk to an analyst

APO RESEARCH · REPORT

Implantable Coronary Drug Eluting Stent

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Implantable Coronary Drug Eluting Stent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025195 pages

Choose your research edition.

Industry ResearchImplantable Coronary Drug Eluting Stent Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Implantable Coronary Drug Eluting Stent Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Implantable Coronary Drug Eluting Stent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Implantable Coronary Drug Eluting Stent Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Implantable Coronary Drug Eluting Stent Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Implantable Coronary Drug Eluting Stent market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Implantable Coronary Drug Eluting Stent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Implantable Coronary Drug Eluting Stent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Implantable Coronary Drug Eluting Stent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Implantable Coronary Drug Eluting Stent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Implantable Coronary Drug Eluting Stent include Yinyi Biotech, Abbott, Microport Medical, SINOMED, Beijing Amsino Medical, Medtronic, Lepu Medical, Boston Scientific and Terumo, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Implantable Coronary Drug Eluting Stent market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Implantable Coronary Drug Eluting Stent and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Implantable Coronary Drug Eluting Stent sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Implantable Coronary Drug Eluting Stent market size, projected growth trends, production technologies, key applications, and end-use industries.

Implantable Coronary Drug Eluting Stent Segment by Company

Yinyi Biotech

Abbott

Microport Medical

SINOMED

Beijing Amsino Medical

Medtronic

Lepu Medical

Boston Scientific

Terumo

Drug-eluting Stent

Implantable Coronary Drug Eluting Stent Segment by Type

Rapamycin

Everolimus

Paclitaxel

Other

Implantable Coronary Drug Eluting Stent Segment by Application

Angina Pectoris

Myocardial Infarction

Others

Implantable Coronary Drug Eluting Stent Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Implantable Coronary Drug Eluting Stent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Implantable Coronary Drug Eluting Stent and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Implantable Coronary Drug Eluting Stent.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Implantable Coronary Drug Eluting Stent market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Implantable Coronary Drug Eluting Stent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Implantable Coronary Drug Eluting Stent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Implantable Coronary Drug Eluting Stent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Implantable Coronary Drug Eluting Stent Industry Trends Table 2. Implantable Coronary Drug Eluting Stent Industry Drivers Table 3. Implantable Coronary Drug Eluting Stent Industry Opportunities and Challenges Table 4. Implantable Coronary Drug Eluting Stent Industry Restraints Table 5. Global Implantable Coronary Drug Eluting Stent Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Implantable Coronary Drug Eluting Stent Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Implantable Coronary Drug Eluting Stent Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Implantable Coronary Drug Eluting Stent Sales Market Share by Manufacturers Table 9. Global Implantable Coronary Drug Eluting Stent Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Implantable Coronary Drug Eluting Stent Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Implantable Coronary Drug Eluting Stent Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Implantable Coronary Drug Eluting Stent Manufacturers, Product Type & Application Table 13. Global Implantable Coronary Drug Eluting Stent Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Implantable Coronary Drug Eluting Stent by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Rapamycin Table 17. Major Manufacturers of Everolimus Table 18. Major Manufacturers of Paclitaxel Table 19. Major Manufacturers of Other Table 20. Global Implantable Coronary Drug Eluting Stent Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Implantable Coronary Drug Eluting Stent Sales by Type (2021-2026) & (K Units) Table 22. Global Implantable Coronary Drug Eluting Stent Sales by Type (2027-2032) & (K Units) Table 23. Global Implantable Coronary Drug Eluting Stent Sales Market Share by Type (2021-2026) Table 24. Global Implantable Coronary Drug Eluting Stent Sales Market Share by Type (2027-2032) Table 25. Global Implantable Coronary Drug Eluting Stent Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Implantable Coronary Drug Eluting Stent Revenue by Type (2021-2026) & (K Units) Table 27. Global Implantable Coronary Drug Eluting Stent Revenue by Type (2027-2032) & (K Units) Table 28. Global Implantable Coronary Drug Eluting Stent Revenue Market Share by Type (2021-2026) Table 29. Global Implantable Coronary Drug Eluting Stent Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Angina Pectoris Table 31. Major Manufacturers of Myocardial Infarction Table 32. Major Manufacturers of Others Table 33. Global Implantable Coronary Drug Eluting Stent Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Implantable Coronary Drug Eluting Stent Sales by Application (2021-2026) & (K Units) Table 35. Global Implantable Coronary Drug Eluting Stent Sales by Application (2027-2032) & (K Units) Table 36. Global Implantable Coronary Drug Eluting Stent Sales Market Share by Application (2021-2026) Table 37. Global Implantable Coronary Drug Eluting Stent Sales Market Share by Application (2027-2032) Table 38. Global Implantable Coronary Drug Eluting Stent Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Implantable Coronary Drug Eluting Stent Revenue by Application (2021-2026) & (K Units) Table 40. Global Implantable Coronary Drug Eluting Stent Revenue by Application (2027-2032) & (K Units) Table 41. Global Implantable Coronary Drug Eluting Stent Revenue Market Share by Application (2021-2026) Table 42. Global Implantable Coronary Drug Eluting Stent Revenue Market Share by Application (2027-2032) Table 43. Global Implantable Coronary Drug Eluting Stent Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Implantable Coronary Drug Eluting Stent Sales by Region (2021-2026) & (K Units) Table 45. Global Implantable Coronary Drug Eluting Stent Sales Market Share by Region (2021-2026) Table 46. Global Implantable Coronary Drug Eluting Stent Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Implantable Coronary Drug Eluting Stent Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Implantable Coronary Drug Eluting Stent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Implantable Coronary Drug Eluting Stent Sales by Country (2021-2026) & (K Units) Table 50. North America Implantable Coronary Drug Eluting Stent Sales by Country (2027-2032) & (K Units) Table 51. Europe Implantable Coronary Drug Eluting Stent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Implantable Coronary Drug Eluting Stent Sales by Country (2021-2026) & (K Units) Table 53. Europe Implantable Coronary Drug Eluting Stent Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Implantable Coronary Drug Eluting Stent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Implantable Coronary Drug Eluting Stent Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Implantable Coronary Drug Eluting Stent Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Implantable Coronary Drug Eluting Stent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Implantable Coronary Drug Eluting Stent Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Implantable Coronary Drug Eluting Stent Sales by Country (2027-2032) & (K Units) Table 60. Global Implantable Coronary Drug Eluting Stent Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Implantable Coronary Drug Eluting Stent Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Implantable Coronary Drug Eluting Stent Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Implantable Coronary Drug Eluting Stent Revenue Market Share by Region (2021-2026) Table 64. Global Implantable Coronary Drug Eluting Stent Revenue Market Share by Region (2027-2032) Table 65. Yinyi Biotech Company Information Table 66. Yinyi Biotech Business Overview Table 67. Yinyi Biotech Implantable Coronary Drug Eluting Stent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Yinyi Biotech Implantable Coronary Drug Eluting Stent Product Portfolio Table 69. Yinyi Biotech Recent Development Table 70. Abbott Company Information Table 71. Abbott Business Overview Table 72. Abbott Implantable Coronary Drug Eluting Stent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Abbott Implantable Coronary Drug Eluting Stent Product Portfolio Table 74. Abbott Recent Development Table 75. Microport Medical Company Information Table 76. Microport Medical Business Overview Table 77. Microport Medical Implantable Coronary Drug Eluting Stent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Microport Medical Implantable Coronary Drug Eluting Stent Product Portfolio Table 79. Microport Medical Recent Development Table 80. SINOMED Company Information Table 81. SINOMED Business Overview Table 82. SINOMED Implantable Coronary Drug Eluting Stent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. SINOMED Implantable Coronary Drug Eluting Stent Product Portfolio Table 84. SINOMED Recent Development Table 85. Beijing Amsino Medical Company Information Table 86. Beijing Amsino Medical Business Overview Table 87. Beijing Amsino Medical Implantable Coronary Drug Eluting Stent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Beijing Amsino Medical Implantable Coronary Drug Eluting Stent Product Portfolio Table 89. Beijing Amsino Medical Recent Development Table 90. Medtronic Company Information Table 91. Medtronic Business Overview Table 92. Medtronic Implantable Coronary Drug Eluting Stent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Medtronic Implantable Coronary Drug Eluting Stent Product Portfolio Table 94. Medtronic Recent Development Table 95. Lepu Medical Company Information Table 96. Lepu Medical Business Overview Table 97. Lepu Medical Implantable Coronary Drug Eluting Stent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Lepu Medical Implantable Coronary Drug Eluting Stent Product Portfolio Table 99. Lepu Medical Recent Development Table 100. Boston Scientific Company Information Table 101. Boston Scientific Business Overview Table 102. Boston Scientific Implantable Coronary Drug Eluting Stent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Boston Scientific Implantable Coronary Drug Eluting Stent Product Portfolio Table 104. Boston Scientific Recent Development Table 105. Terumo Company Information Table 106. Terumo Business Overview Table 107. Terumo Implantable Coronary Drug Eluting Stent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Terumo Implantable Coronary Drug Eluting Stent Product Portfolio Table 109. Terumo Recent Development Table 110. Drug-eluting Stent Company Information Table 111. Drug-eluting Stent Business Overview Table 112. Drug-eluting Stent Implantable Coronary Drug Eluting Stent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Drug-eluting Stent Implantable Coronary Drug Eluting Stent Product Portfolio Table 114. Drug-eluting Stent Recent Development Table 115. Key Raw Materials Table 116. Raw Materials Key Suppliers Table 117. Implantable Coronary Drug Eluting Stent Distributors List Table 118. Implantable Coronary Drug Eluting Stent Customers List Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Implantable Coronary Drug Eluting Stent Product Image Figure 2. Global Implantable Coronary Drug Eluting Stent Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Implantable Coronary Drug Eluting Stent Market Size (2021-2032) & (US$ Million) Figure 4. Global Implantable Coronary Drug Eluting Stent Sales (2021-2032) & (K Units) Figure 5. Global Implantable Coronary Drug Eluting Stent Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Implantable Coronary Drug Eluting Stent Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Rapamycin Image Figure 9. Everolimus Image Figure 10. Paclitaxel Image Figure 11. Other Image Figure 12. Global Implantable Coronary Drug Eluting Stent Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Implantable Coronary Drug Eluting Stent Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Implantable Coronary Drug Eluting Stent Sales Market Share by Type (2021-2032) Figure 15. Global Implantable Coronary Drug Eluting Stent Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Implantable Coronary Drug Eluting Stent Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Implantable Coronary Drug Eluting Stent Revenue Market Share by Type (2021-2032) Figure 18. Angina Pectoris Image Figure 19. Myocardial Infarction Image Figure 20. Others Image Figure 21. Global Implantable Coronary Drug Eluting Stent Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Implantable Coronary Drug Eluting Stent Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Implantable Coronary Drug Eluting Stent Sales Market Share by Application (2021-2032) Figure 24. Global Implantable Coronary Drug Eluting Stent Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Implantable Coronary Drug Eluting Stent Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Implantable Coronary Drug Eluting Stent Revenue Market Share by Application (2021-2032) Figure 27. North America Implantable Coronary Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Implantable Coronary Drug Eluting Stent Sales Market Share by Country (2021-2032) Figure 29. U.S. Implantable Coronary Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Implantable Coronary Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Implantable Coronary Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Implantable Coronary Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Implantable Coronary Drug Eluting Stent Sales Market Share by Country (2021-2032) Figure 34. Germany Implantable Coronary Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Implantable Coronary Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Implantable Coronary Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Implantable Coronary Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Implantable Coronary Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Implantable Coronary Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Implantable Coronary Drug Eluting Stent Sales Market Share by Country (2021-2032) Figure 41. China Implantable Coronary Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Implantable Coronary Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Implantable Coronary Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Implantable Coronary Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Implantable Coronary Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Implantable Coronary Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Implantable Coronary Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Implantable Coronary Drug Eluting Stent Sales Market Share by Country (2021-2032) Figure 49. Brazil Implantable Coronary Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Implantable Coronary Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Implantable Coronary Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Implantable Coronary Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Implantable Coronary Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Implantable Coronary Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Implantable Coronary Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Implantable Coronary Drug Eluting Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Implantable Coronary Drug Eluting Stent Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Implantable Coronary Drug Eluting Stent Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Implantable Coronary Drug Eluting Stent Revenue (2021-2032) & (US$ Million) Figure 60. North America Implantable Coronary Drug Eluting Stent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Implantable Coronary Drug Eluting Stent Revenue (2021-2032) & (US$ Million) Figure 62. Europe Implantable Coronary Drug Eluting Stent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Implantable Coronary Drug Eluting Stent Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Implantable Coronary Drug Eluting Stent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Implantable Coronary Drug Eluting Stent Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Implantable Coronary Drug Eluting Stent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Implantable Coronary Drug Eluting Stent Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Implantable Coronary Drug Eluting Stent Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Rapamycin
  • Everolimus
  • Paclitaxel
  • Other
Applications
  • Angina Pectoris
  • Myocardial Infarction
  • Others
Companies covered
  • Yinyi Biotech
  • Abbott
  • Microport Medical
  • SINOMED
  • Beijing Amsino Medical
  • Medtronic
  • Lepu Medical
  • Boston Scientific
  • Terumo
  • Drug-eluting Stent

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Implantable Coronary Drug Eluting Stent Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Implantable Coronary Drug Eluting Stent Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Implantable Coronary Drug Eluting Stent Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Implantable Coronary Drug Eluting Stent Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Implantable Coronary Drug Eluting Stent Market Dynamics
  1. 2.1 Implantable Coronary Drug Eluting Stent Industry Trends
  2. 2.2 Implantable Coronary Drug Eluting Stent Industry Drivers
  3. 2.3 Implantable Coronary Drug Eluting Stent Industry Opportunities and Challenges
  4. 2.4 Implantable Coronary Drug Eluting Stent Industry Restraints
3 Implantable Coronary Drug Eluting Stent Market by Manufacturers
  1. 3.1 Global Implantable Coronary Drug Eluting Stent Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Implantable Coronary Drug Eluting Stent Sales by Manufacturers (2021-2026)
  3. 3.3 Global Implantable Coronary Drug Eluting Stent Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Implantable Coronary Drug Eluting Stent Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Implantable Coronary Drug Eluting Stent Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Implantable Coronary Drug Eluting Stent Manufacturers, Product Type & Application
  7. 3.7 Global Implantable Coronary Drug Eluting Stent Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Implantable Coronary Drug Eluting Stent Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Implantable Coronary Drug Eluting Stent Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Implantable Coronary Drug Eluting Stent Tier 1, Tier 2, and Tier 3
4 Implantable Coronary Drug Eluting Stent Market by Type
  1. 4.1 Implantable Coronary Drug Eluting Stent Type Introduction
  2. 4.1.1 Rapamycin
  3. 4.1.2 Everolimus
  4. 4.1.3 Paclitaxel
  5. 4.1.4 Other
  6. 4.2 Global Implantable Coronary Drug Eluting Stent Sales by Type
  7. 4.2.1 Global Implantable Coronary Drug Eluting Stent Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Implantable Coronary Drug Eluting Stent Sales by Type (2021-2032)
  9. 4.2.3 Global Implantable Coronary Drug Eluting Stent Sales Market Share by Type (2021-2032)
  10. 4.3 Global Implantable Coronary Drug Eluting Stent Revenue by Type
  11. 4.3.1 Global Implantable Coronary Drug Eluting Stent Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Implantable Coronary Drug Eluting Stent Revenue by Type (2021-2032)
  13. 4.3.3 Global Implantable Coronary Drug Eluting Stent Revenue Market Share by Type (2021-2032)
5 Implantable Coronary Drug Eluting Stent Market by Application
  1. 5.1 Implantable Coronary Drug Eluting Stent Application Introduction
  2. 5.1.1 Angina Pectoris
  3. 5.1.2 Myocardial Infarction
  4. 5.1.3 Others
  5. 5.2 Global Implantable Coronary Drug Eluting Stent Sales by Application
  6. 5.2.1 Global Implantable Coronary Drug Eluting Stent Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Implantable Coronary Drug Eluting Stent Sales by Application (2021-2032)
  8. 5.2.3 Global Implantable Coronary Drug Eluting Stent Sales Market Share by Application (2021-2032)
  9. 5.3 Global Implantable Coronary Drug Eluting Stent Revenue by Application
  10. 5.3.1 Global Implantable Coronary Drug Eluting Stent Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Implantable Coronary Drug Eluting Stent Revenue by Application (2021-2032)
  12. 5.3.3 Global Implantable Coronary Drug Eluting Stent Revenue Market Share by Application (2021-2032)
6 Global Implantable Coronary Drug Eluting Stent Sales by Region
  1. 6.1 Global Implantable Coronary Drug Eluting Stent Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Implantable Coronary Drug Eluting Stent Sales by Region (2021-2032)
  3. 6.2.1 Global Implantable Coronary Drug Eluting Stent Sales by Region (2021-2026)
  4. 6.2.2 Global Implantable Coronary Drug Eluting Stent Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Implantable Coronary Drug Eluting Stent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Implantable Coronary Drug Eluting Stent Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Implantable Coronary Drug Eluting Stent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Implantable Coronary Drug Eluting Stent Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Implantable Coronary Drug Eluting Stent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Implantable Coronary Drug Eluting Stent Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Implantable Coronary Drug Eluting Stent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Implantable Coronary Drug Eluting Stent Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Implantable Coronary Drug Eluting Stent Revenue by Region
  1. 7.1 Global Implantable Coronary Drug Eluting Stent Revenue by Region
  2. 7.1.1 Global Implantable Coronary Drug Eluting Stent Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Implantable Coronary Drug Eluting Stent Revenue by Region (2021-2026)
  4. 7.1.3 Global Implantable Coronary Drug Eluting Stent Revenue by Region (2027-2032)
  5. 7.1.4 Global Implantable Coronary Drug Eluting Stent Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Implantable Coronary Drug Eluting Stent Revenue (2021-2032)
  8. 7.2.2 North America Implantable Coronary Drug Eluting Stent Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Implantable Coronary Drug Eluting Stent Revenue (2021-2032)
  11. 7.3.2 Europe Implantable Coronary Drug Eluting Stent Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Implantable Coronary Drug Eluting Stent Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Implantable Coronary Drug Eluting Stent Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Implantable Coronary Drug Eluting Stent Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Implantable Coronary Drug Eluting Stent Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Yinyi Biotech
  2. 8.1.1 Yinyi Biotech Company Information
  3. 8.1.2 Yinyi Biotech Business Overview
  4. 8.1.3 Yinyi Biotech Implantable Coronary Drug Eluting Stent Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Yinyi Biotech Implantable Coronary Drug Eluting Stent Product Portfolio
  6. 8.1.5 Yinyi Biotech Recent Developments
  7. 8.2 Abbott
  8. 8.2.1 Abbott Company Information
  9. 8.2.2 Abbott Business Overview
  10. 8.2.3 Abbott Implantable Coronary Drug Eluting Stent Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Abbott Implantable Coronary Drug Eluting Stent Product Portfolio
  12. 8.2.5 Abbott Recent Developments
  13. 8.3 Microport Medical
  14. 8.3.1 Microport Medical Company Information
  15. 8.3.2 Microport Medical Business Overview
  16. 8.3.3 Microport Medical Implantable Coronary Drug Eluting Stent Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Microport Medical Implantable Coronary Drug Eluting Stent Product Portfolio
  18. 8.3.5 Microport Medical Recent Developments
  19. 8.4 SINOMED
  20. 8.4.1 SINOMED Company Information
  21. 8.4.2 SINOMED Business Overview
  22. 8.4.3 SINOMED Implantable Coronary Drug Eluting Stent Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 SINOMED Implantable Coronary Drug Eluting Stent Product Portfolio
  24. 8.4.5 SINOMED Recent Developments
  25. 8.5 Beijing Amsino Medical
  26. 8.5.1 Beijing Amsino Medical Company Information
  27. 8.5.2 Beijing Amsino Medical Business Overview
  28. 8.5.3 Beijing Amsino Medical Implantable Coronary Drug Eluting Stent Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Beijing Amsino Medical Implantable Coronary Drug Eluting Stent Product Portfolio
  30. 8.5.5 Beijing Amsino Medical Recent Developments
  31. 8.6 Medtronic
  32. 8.6.1 Medtronic Company Information
  33. 8.6.2 Medtronic Business Overview
  34. 8.6.3 Medtronic Implantable Coronary Drug Eluting Stent Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Medtronic Implantable Coronary Drug Eluting Stent Product Portfolio
  36. 8.6.5 Medtronic Recent Developments
  37. 8.7 Lepu Medical
  38. 8.7.1 Lepu Medical Company Information
  39. 8.7.2 Lepu Medical Business Overview
  40. 8.7.3 Lepu Medical Implantable Coronary Drug Eluting Stent Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Lepu Medical Implantable Coronary Drug Eluting Stent Product Portfolio
  42. 8.7.5 Lepu Medical Recent Developments
  43. 8.8 Boston Scientific
  44. 8.8.1 Boston Scientific Company Information
  45. 8.8.2 Boston Scientific Business Overview
  46. 8.8.3 Boston Scientific Implantable Coronary Drug Eluting Stent Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Boston Scientific Implantable Coronary Drug Eluting Stent Product Portfolio
  48. 8.8.5 Boston Scientific Recent Developments
  49. 8.9 Terumo
  50. 8.9.1 Terumo Company Information
  51. 8.9.2 Terumo Business Overview
  52. 8.9.3 Terumo Implantable Coronary Drug Eluting Stent Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Terumo Implantable Coronary Drug Eluting Stent Product Portfolio
  54. 8.9.5 Terumo Recent Developments
  55. 8.10 Drug-eluting Stent
  56. 8.10.1 Drug-eluting Stent Company Information
  57. 8.10.2 Drug-eluting Stent Business Overview
  58. 8.10.3 Drug-eluting Stent Implantable Coronary Drug Eluting Stent Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Drug-eluting Stent Implantable Coronary Drug Eluting Stent Product Portfolio
  60. 8.10.5 Drug-eluting Stent Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Implantable Coronary Drug Eluting Stent Value Chain Analysis
  2. 9.1.1 Implantable Coronary Drug Eluting Stent Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Implantable Coronary Drug Eluting Stent Production Mode & Process
  6. 9.2 Implantable Coronary Drug Eluting Stent Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Implantable Coronary Drug Eluting Stent Distributors
  9. 9.2.3 Implantable Coronary Drug Eluting Stent Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst